Observational studyMedicine2015

Docetaxel/S-1 Versus Docetaxel/Capecitabine as First-Line Treatment for Advanced Breast Cancer: A Retrospective Study.

Jinyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.